Alpha-9 Theranostics Revenue and Competitors
Estimated Revenue & Valuation
- Alpha-9 Theranostics's estimated annual revenue is currently $2.6M per year.
- Alpha-9 Theranostics's estimated revenue per employee is $77,500
- Alpha-9 Theranostics's total funding is $9M.
Employee Data
- Alpha-9 Theranostics has 34 Employees.
- Alpha-9 Theranostics grew their employee count by 127% last year.
Alpha-9 Theranostics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Founder | Reveal Email/Phone |
4 | Founder | Reveal Email/Phone |
5 | Founder | Reveal Email/Phone |
6 | COO | Reveal Email/Phone |
7 | Senior Director, Clinical Operations | Reveal Email/Phone |
8 | Senior Director Finance | Reveal Email/Phone |
9 | Associate Scientist II | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
Alpha-9 Theranostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.1M | 40 | 18% | $40M | N/A |
#2 | $0.2M | 2 | 0% | N/A | N/A |
#3 | $1.3M | 17 | -15% | N/A | N/A |
#4 | $2.6M | 17 | 6% | N/A | N/A |
#5 | $12.9M | 83 | 5% | N/A | N/A |
#6 | $1.9M | 24 | 4% | $89.5M | N/A |
#7 | $2.8M | 18 | 6% | N/A | N/A |
#8 | $40.3M | 260 | 21% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Alpha-9 Theranostics?
Alpha-9 Theranostics is a clinical-stage, radiopharmaceutical company based in Vancouver using molecularly targeted radiopharmaceuticals for the improved diagnosis and treatment of metastatic cancer. The Company is developing new theranostic products based on breakthrough technology developed by the scientific founders and exclusively licensed from the University of British Columbia and BC Cancer.
keywords:N/A
$9M
Total Funding
34
Number of Employees
$2.6M
Revenue (est)
127%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alpha-9 Theranostics News
Core Material Used for Targeted Alpha Therapy (TAT) Expected to Be Novel ... of Theranostics by promoting a research project (*9) adopted in...
Eckert & Ziegler (ISIN DE0005659700, TecDAX) hat mit dem kanadischen Biotechunternehmen Alpha-9 Theranostics Inc. (Alpha-9) einen Vertrag...
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.6M | 34 | 0% | N/A |
#2 | $9.8M | 34 | -68% | $494.1M |
#3 | $7.5M | 34 | 6% | N/A |
#4 | $6.7M | 34 | -3% | N/A |
#5 | $3.9M | 34 | -3% | N/A |